NasdaqCM:CORTPharmaceuticals
A Look At Corcept Therapeutics (CORT) Valuation After Its Strong Recent Share Price Rebound
Recent return profile and business snapshot
Corcept Therapeutics (CORT) has drawn fresh attention after a strong recent share price run, with the stock up 1.1% over the past day, 2.4% over the past week and 32.4% over the past month.
Over the past 3 months, the stock is up 71.4%, while the past year shows a total return decline of 21.6%. Longer horizons look different, with total returns of 143.4% over 3 years and 175.4% over 5 years.
The company, headquartered in Redwood City, California,...